 Burger's Medicinal Chemistry and Drug Discovery, Volume 5, Chemotherapeutic Agents, 6th Edition
ISBN: 978-0-471-37031-4
Hardcover
1152 pages
March 2003
US $480.00
 Add to Cart
This price is valid for United States. Change location to view local pricing and availability. |
Instructors may request an evaluation copy for this title.
|
2. SYNTHETIC DNA-TARGETED CHEMOTHERAPEUTIC AGENTS AND RELATED TUMORACTIVATED PRODRUGS (William A. Denny, Auckland Cancer Society Research Centre Faculty of Medical and Health Sciences The University of Auckland Auckland, New Zealand).
3. ANTITUMOR NATURAL PRODUCTS (Lester A. Mitscher & Apurba Dutta, Department of Medicinal Chemistry Kansas University Lawrence, Kansas).
4. RADIOSENSITIZERS AND RADIOPROTECTIVE AGENTS (Edward A. Bump, DRAXIMAGE Inc. Kirkland, Quebec, Canada; Stephen J. Hoffman, Allos Therapeutics, Inc. Westminster, Colorado; William O. Foye, Massachusetts College of Pharmacy and Health Sciences Boston, Massachusetts).
5. SYNTHETIC ANTIANGIOGENIC AGENTS (Orest W. Blaschuk, Mc Gill University, Royal Victoria Hospital Montreal, Quebec, Canada; J. Matthew Symonds, Adherex Technologies Inc. Ottawa, Ontario, Canada).
6. FUTURE STRATEGIES IN IMMUNOTHERAPY (Douglas F. Lake & Sara O. Dionne, University of Arizona Cancer Center Tucson, Arizona).
7. SELECTIVE TOXICITY (John H. Block, College of Pharmacy Oregon State University Corvallis, Oregon).
8. DRUG RESISTANCE IN CANCER CHEMOTHERAPY (Amelia M. Wall, Division of Clinical Pharmacology and Therapeutics, Children’s Hospital of Philadelphia, Cancer Pharmacology Institute, University of Pennsylvania Philadelphia, Pennsylvania).
9. ANTIVIRAL AGENTS, DNA (Tim Middleton & Todd Rockway, Abbott Laboratories Abbott Park, Illinois).
10. ANTIVIRAL AGENTS, RNA VIRUSES (OTHER THAN HIV), AND ORTHOPOXVIRUSES (Christopher Tseng & Catherine Laughlin, NIAID, National Institutes of Health, Bethesda, Maryland).
11. RATIONALE OF DESIGN OF ANTI-HIV DRUGS (Ahmed S. Mehanna, Massachusetts College of Pharmacy and Health Sciences, Department of Pharmaceutical Sciences, School of Pharmacy Boston, Massachusetts).
12. ORGAN TRANSPLANT DRUGS (Bijoy Kundu, Medicinal Chemistry Division, Central Drug Research Institute Lucknow, India).
13. SYNTHETIC ANTIBACTERIAL AGENTS (Nitya Anand, B-62, Nirala Nagar, Lucknow, India; William A. Remers, University of Arizona, College of Pharmacy Tucson, Arizona).
14. ß-LACTAM ANTIBIOTICS (Daniele Andreotti, Stefano Biondi, Enza Di Modugno, GlaxoSmithKline Research Center Verona, Italy)
15. TETRACYCLINE, AMINOGLYCOSIDE, MACROLIDE, AND MISCELLANEOUS ANTIBIOTICS (Gerard D. Wright, Antimicrobial Research Centre, Department of Biochemistry, McMaster University, Hamilton, Ontario, Canada; Daniel T. W. Chu, Chiron Corporation Emeryville, California).
16. ANTIMYCOBACTERIAL AGENTS (Piero Sensi, University of Milan Milan, Italy; Giuliana Gialdroni Grassi, University of Pavia Pavia, Italy).
17. ANTIFUNGAL AGENTS (William J. Watkins & Thomas E. Renau, Essential Therapeutics Mountain View, California).
18. ANTIMALARIAL AGENTS (Dee Ann Casteel, Department of Chemistry, Bucknell University Lewisburg, Pennsylvania).
19. ANTIPROTOZOAL AGENTS (David S. Fries, TJ Long School of Pharmacy, University of the Pacific Stockton, California; Alan H. Fairlamb, Division of Biological Chemistry and Molecular Microbiology, The Wellcome Trust Biocentre, University of Dundee, Dundee, United Kingdom).
20. ANTHELMINTICS (Robert K. Griffith, West Virginia University, School of Pharmacy, Morgantown, West Virginia).
INDEX.
;){kind=link}